Browsing the Innovatio ND2 ( Pd) website ...
https://en.innovatio-nd2.com/Under the banner/button " Innovatio " ... came across some details
that seem relevant...imo...concerning the sensitivity of the Pd test..
Can you imagine the benefit and value to Patients , Doctors and Payers
to have a test that can monitor from one test to the next any changes to
medication ...definitely in the field of Precision medicine
Anyway... I immediately I thought of our collaboration with J&J ...this is where we are
monitoring through Pd the responsiveness of patients to Canagliflozin and
how that is reflected in their risk profile for CKD ...
I'll leave you to join the dots ....from the AGM webcast ...Dr RL mentioned that the
J&J collaboration results will likely be "first cab off the rank "
glta
(20min delay)